Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q4 2016 Earnings

31MarExpected
Q1 2016
Q2 2016
Q3 2016
Q4 2016
-5,100
-3,660
-2,220
-780

Details

Expected EPS
-780
Actual EPS
-2310
Surprise EPS
-1,530
Surprise Percent
+196.15%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -2310 per share for Q4 2016.

0 Comments

Share your thoughts